WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-31
DOI
10.1038/s41388-019-0700-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- Targeting cancer stem cells in the clinic: Current status and perspectives
- (2018) Stephanie Annett et al. PHARMACOLOGY & THERAPEUTICS
- STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
- (2018) Jung-Mao Hsu et al. Nature Communications
- PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
- (2017) Sheema Almozyan et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer
- (2017) António Polónia et al. JOURNAL OF CLINICAL PATHOLOGY
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016
- (2017) Paolo A. Ascierto et al. Journal of Translational Medicine
- Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
- (2017) Clinton Yam et al. ONCOLOGIST
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Abstract P2-11-06: Safety and clinical activity of atezolizumab (anti-PDL1) in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer
- (2016) S Adams et al. CANCER RESEARCH
- CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1
- (2016) Y. Lee et al. CLINICAL CANCER RESEARCH
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- Cartoon filter via adaptive abstraction
- (2016) Davide Guastella et al. JOURNAL OF VISUAL COMMUNICATION AND IMAGE REPRESENTATION
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity
- (2016) Sabina Sangaletti et al. Cell Reports
- WAVELET ANALYSIS AND NEURAL NETWORK CLASSIFIERS TO DETECT MID-SAGITTAL SECTIONS FOR NUCHAL TRANSLUCENCY MEASUREMENT
- (2016) Giuseppa Sciortino et al. Image Analysis & Stereology
- Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
- (2015) Abdullah Alsuliman et al. Molecular Cancer
- Targeting the WNT Signaling Pathway in Cancer Therapeutics
- (2015) D. Tai et al. ONCOLOGIST
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
- (2015) Gyu-Beom Jang et al. Scientific Reports
- Subtyping of triple-negative breast cancer: Implications for therapy
- (2014) Vandana G. Abramson et al. CANCER
- The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy
- (2014) Simone Muenst et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?
- (2014) Valentin S. Bruttel et al. Frontiers in Immunology
- A New Spontaneously Transformed Syngeneic Model of High-Grade Serous Ovarian Cancer with a Tumor-Initiating Cell Population
- (2014) Curtis W. McCloskey et al. Frontiers in Oncology
- Wnt signaling in triple negative breast cancer is associated with metastasis
- (2013) Nandini Dey et al. BMC CANCER
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- Using a Stem Cell-Based Signature to Guide Therapeutic Selection in Cancer
- (2010) I. Shats et al. CANCER RESEARCH
- β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
- (2010) Felipe C Geyer et al. MODERN PATHOLOGY
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- AmiGO: online access to ontology and annotation data
- (2008) Seth Carbon et al. BIOINFORMATICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started